News search results
90 Results for ''
- 
  
    AwardsCharles Park named 2025 STAT Wunderkind  
 October 17, 2025
- 
  
    Press ReleaseToward recreating the brain’s immune system in a dish  
 June 10, 2025
- 
  
    Press ReleaseWyss Institute at Harvard University announces appointment of Natalie Artzi to Associate Institute Director  
 May 29, 2025
- 
  
    CommunitySandy Elmehrath on Closing the Gender Health Gap by Driving Progress in Endometriosis Management and Care  
 March 25, 2025
- 
  
    CommunityReimagining infectious disease treatment for greater health equity: Kwasi Adu-Berchie  
 March 18, 2025
- 
  
    AwardsVision for whole eye transplant  
 February 12, 2025
- 
  
    AwardsARPA-H-recognized iNode team seeks vital support to treat ovarian cancer with first-in-class implantable immune organs  
 January 30, 2025
- 
  
    AwardsWyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer  
 November 12, 2024
- 
  
    AwardsKwasi Adu-Berchie named 2024 STAT Wunderkind  
 October 16, 2024
- 
  
    Translation NewsAttivare licenses Wyss Institute’s immune-modulating biomaterial technology to advance immunotherapies  
 October 2, 2024
- 
  
    Press ReleaseWyss Institute team selected by DARPA-SHIELD program to develop first-of-its-kind biologically engineered broad-spectrum antimicrobial therapeutic  
 September 16, 2024
- 
  
    CommunityVinny Chandran Suja on Making Backpacks More Reliable and Predictable  
 August 20, 2024
- 
  
    Press ReleaseWyss Institute promotes Natalie Artzi to its Core Faculty and appoints Di Feng as an Associate Faculty member  
 August 12, 2024
- 
  
    AwardsWyss Institute Research Collaboration Awarded ARPA-H Agreement to Develop Disease-Agnostic Immunotherapeutic RNA Platform  
 July 15, 2024
- 
  
    Press ReleaseBoosting CAR-T cell therapies from under the skin  
 June 12, 2024
- 
  
    AwardsThe Wyss Institute’s 2024-2025 Validation Projects  
 May 29, 2024
- 
  
    Press ReleaseExpanding a lymph node, boosting a vaccine  
 May 6, 2024
- 
  
    Translation NewsIn a first, genetically edited pig kidney is transplanted into human  
 March 22, 2024
- 
  
    Press ReleaseEmpty “backpacks” activate the immune system against cancer  
 March 19, 2024
- 
  
    Press ReleaseDNA origami-based vaccines toward safe and highly-effective precision cancer immunotherapy  
 March 15, 2024
- 
  
    Research SpotlightsAnnouncing the 2024 “Faculty Focus” List  
 January 25, 2024
- 
  
    Research SpotlightsChanging the calculus of cancer treatment  
 January 25, 2024
- 
  
    Press ReleaseUsing the body’s own cells to treat traumatic brain injury  
 January 3, 2024
- 
  
    Press ReleaseShining a light on the hidden damage of mild brain injuries  
 January 3, 2024
- 
  
    Research SpotlightsShape-shifting immune cells offer new insights into cancer immunotherapy  
 November 17, 2023
- 
  
    Translation NewsThe Wyss Institute’s 2023-2024 Validation Projects  
 October 19, 2023
- 
  
    Press ReleaseAdding immunity to human kidney-on-a-chip advances cancer drug testing  
 August 23, 2023
- 
  
    Press ReleaseMoving the needle on monitoring skin cancer  
 August 21, 2023
- 
  
    Press ReleaseBiomaterial-delivered one-two punch boosts cancer immunotherapy  
 July 13, 2023
- 
  
    Press ReleaseTuning T cell traits and functions with biomechanical materials  
 June 26, 2023
- 
  
    CommunityNeha Kapate on Backpacking her way into a New Frontier for Treating Incurable Diseases  
 June 23, 2023
- 
  
    Press ReleaseA backpack full of multiple sclerosis therapy  
 April 21, 2023
- 
  
    Research SpotlightsImmunotherapy’s Next Act  
 March 15, 2023
- 
  
    Press ReleaseCAR-T cell cancer immunotherapy gets personal  
 February 10, 2023
- 
  
    Press ReleaseEnhanced cancer immunotherapies through cytokine-labeled T cells  
 January 10, 2023
- 
  
    AwardsElizabeth Carstens and Yang Claire Zeng selected as 3rd recipients of Harvard’s “Immuno-engineering to Improve Immunotherapy” (i3) Center award  
 December 14, 2022
- 
  
    Press ReleaseWyss researchers discover a new type of RNA that inhibits a broad range of viral infections  
 October 5, 2022
- 
  
    Research SpotlightsActivating STING could make brain tumors more susceptible to treatment  
 July 14, 2022
- 
  
    Press ReleaseDeconstructing the mechanics of bone marrow disease  
 July 11, 2022
- 
  
    Research SpotlightsNew cancer vaccine delivers double punch to tumors  
 May 27, 2022
- 
  
    CommunityNorthpond Labs funds second Wyss Institute research project  
 May 19, 2022
- 
  
    Press ReleaseThe Wyss Institute Welcomes Associate Faculty Member Natalie Artzi, Ph.D.  
 May 9, 2022
- 
  
    Awards“Immuno-engineering to Improve Immunotherapy” (i3) Center at Harvard University selects Dana-Farber cancer-immunologist Rizwan Romee as its 2021 grant recipient  
 December 13, 2021
- 
  
    Press ReleaseBiomaterial vaccines ward off broad range of bacterial infections and septic shock  
 July 8, 2021
- 
  
    Press ReleaseMuscling up with nanoparticle-based anti-inflammatory therapy  
 June 24, 2021
- 
  
    CommunityHaiqing Bai on Understanding and Treating Influenza  
 May 26, 2021
- 
  
    Press ReleaseMachine-learning how to create better AAV gene delivery vehicles  
 February 11, 2021
- 
  
    Press ReleaseA new vision for AAV-delivered gene therapies  
 February 10, 2021
- 
  
    AwardsHarvard “Immuno-engineering to Improve Immunotherapy” (i3) Center at the Wyss Institute awards first grant to Dana-Farber cancer immunologist Eric Smith  
 January 21, 2021
- 
  
    Press ReleaseTurning the problem of cancer metastasis into an opportunity  
 November 16, 2020
- 
  
    CommunityNada Langellotto on OMNIVAX: A Broadly Deployable Infection Vaccine Platform  
 November 12, 2020
- 
  
    Press ReleaseA viable vaccine for tough tumors  
 November 10, 2020
- 
  
    Press ReleaseBetter vaccines are in our blood  
 July 13, 2020
- 
  
    Research Spotlightsi3 Center: Biomaterials to Create T Cell Immunity  
 July 1, 2020
- 
  
    Press ReleaseDirect control of dendritic cells for tracking and immune modulation  
 May 18, 2020
- 
  
    Press Release“Backpacks” boost immune cells’ ability to kill cancer  
 April 29, 2020
- 
  
    Press ReleaseSoup to Nuts  
 April 24, 2020
- 
  
    AwardsHarvard’s Wyss Institute announces cross-institutional “Immuno-engineering to Improve Immunotherapy (i3)” Center to advance cancer therapy  
 March 6, 2020
- 
  
    Research SpotlightsDon’t hate your guts – heal them  
 February 10, 2020
- 
  
    Press ReleaseA solid vaccine for liquid tumors  
 January 14, 2020
- 
  
    Press ReleaseAnother trick up the immune system’s sleeve: regrowing blood vessels  
 July 31, 2019
- 
  
    Research SpotlightsHarnessing Nature to Beat Cancer  
 February 28, 2019
- 
  
    Press ReleasePlatelet “Decoys” Outsmart Both Clots and Cancer  
 February 13, 2019
- 
  
    Press ReleaseSmall molecules come into focus  
 December 7, 2018
- 
  
    Press ReleaseA golden ticket to faster muscle recovery  
 October 1, 2018
- 
  
    Translation NewsHarvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis  
 March 20, 2018
- 
  
    Press ReleasePersonal cancer vaccines get their own boost  
 March 5, 2018
- 
  
    Press ReleaseFast-tracking T cell therapies with immune-mimicking biomaterials  
 January 15, 2018
- 
  
    AwardsWyss Researcher Named 2017 STAT Wunderkind  
 October 13, 2017
- 
  
    Video/AnimationIntroducing ‘Immuno-Materials’ to immunotherapy  
 June 28, 2017
- 
  
    Translation NewsWyss Institute startup, Opsonix Inc., honored with prestigious Spinoff Award  
 May 15, 2017
- 
  
    CommunitySeeing Is Believing: Therapeutic Cancer Vaccines  
 April 5, 2017
- 
  
    Press ReleaseSetting a trap for autoimmunity  
 April 10, 2017
- 
  
    Press ReleaseDavid Mooney elected Fellow of the National Academy of Inventors  
 December 13, 2016
- 
  
    Press ReleaseMaking every cell matter  
 October 31, 2016
- 
  
    Press ReleaseHarvard’s Wyss Institute to lead multi-institutional project to uncover underlying causes of tolerance to infection  
 May 31, 2016
- 
  
    Press ReleaseWyss Institute Founding Director Donald Ingber elected to American Academy of Arts and Sciences  
 April 20, 2016
- 
  
    Press ReleaseModeling COPD and asthma in a human small airway-on-a-chip  
 December 21, 2015
- 
  
    Press ReleaseA cultural revolution in the study of the gut microbiome  
 December 14, 2015
- 
  
    Press ReleaseRemoving 62 barriers to pig-to-human organ transplant in one fell swoop  
 October 11, 2015
- 
  
    Translation NewsWyss Institute launches startup to commercialize new sepsis therapy  
 October 8, 2015
- 
  
    Press ReleaseRe-booting the human gut  
 June 16, 2015
- 
  
    Press ReleaseDavid Mooney receives grant to develop animal contraceptive vaccine  
 January 13, 2015
- 
  
    Press ReleaseInjectable 3D vaccines could fight cancer and infectious diseases  
 December 8, 2014
- 
  
    Press ReleaseCloaked DNA nanodevices survive pilot mission  
 April 22, 2014
- 
  
    Translation NewsCross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials  
 September 6, 2013
- 
  
    Press ReleaseInjectable sponge delivers drugs, cells, and structure  
 November 13, 2012
- 
  
    Press ReleaseWyss Institute Models a Human Disease in an Organ-on-a-Chip  
 November 7, 2012
- 
  
    Press ReleaseResearchers at Harvard’s Wyss Institute Develop DNA Nanorobot to Trigger Targeted Therapeutic Responses  
 February 16, 2012
- 
  
    Press ReleaseFirst cancer vaccine to eliminate tumors in mice  
 November 25, 2009